0001926434-22-000001.txt : 20220511 0001926434-22-000001.hdr.sgml : 20220511 20220511150004 ACCESSION NUMBER: 0001926434-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20220511 DATE AS OF CHANGE: 20220511 EFFECTIVENESS DATE: 20220511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CESSATION THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001926434 IRS NUMBER: 823906297 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-445308 FILM NUMBER: 22913275 BUSINESS ADDRESS: STREET 1: 3031 TISCH WAY, STE. 505 CITY: SAN JOSE STATE: CA ZIP: 95128 BUSINESS PHONE: 408-479-7843 MAIL ADDRESS: STREET 1: 3031 TISCH WAY, STE. 505 CITY: SAN JOSE STATE: CA ZIP: 95128 D 1 primary_doc.xml X0708 D LIVE 0001926434 CESSATION THERAPEUTICS, INC. 3031 TISCH WAY, STE. 505 SAN JOSE CA CALIFORNIA 95128 408-479-7843 DELAWARE None None Corporation true 2022 Mark Pearson 3031 Tisch Way, Ste. 505 San Jose CA CALIFORNIA 95128 Executive Officer Director John Harkey 3031 Tisch Way, Ste. 505 San Jose CA CALIFORNIA 95128 Executive Officer Director Eric Rasmussen 3031 Tisch Way, Ste. 505 San Jose CA CALIFORNIA 95128 Executive Officer David Genecov 3031 Tisch Way, Ste. 505 San Jose CA CALIFORNIA 95128 Director Jay Shepard 3031 Tisch Way, Ste. 505 San Jose CA CALIFORNIA 95128 Director Biotechnology Decline to Disclose 06c false 2022-05-02 false true true true false 0 10000000 5755000 4245000 false 31 0 0 0 false CESSATION THERAPEUTICS, INC. Mark Pearson Mark Pearson CEO 2022-05-11